Skip to main content

Table 4 Performance of HIV/HBV/HCV multiplex POC tests [38]

From: The future of viral hepatitis testing: innovations in testing technologies and approaches

Company Specimen Sensitivity
(95% CI)
Specificity
(95% CI)
OraSure HCV Antibody Test 92.7% (88.8%–96.5%) 99.8% (99.4%–100%)
Chembio HCV Screen 92.1% (87.7%–96.4%) 99.2% (98.6%–99.9%)
  HIV-HCV Assay 91.5% (87.2%–95.7%) 99.4% (98.8%–99.9%)
  HIV-HCV-Syphilis 92.3% (88.4%–96.2%) 99.3% (98.8%–99.9%)
MedMira HIV/HCV 79.1% (72.6%–85.5%) 100%
  HIV/HCV/HBV 81.5% (75.2%–87.8%) 100%